stars 1 stars 2 stars 3

Actelion Pharmaceuticals Ltd., part of the Johnson & Johnson Family of Companies, is a leader in the field of pulmonary arterial hypertension (PAH). Our portfolio of PAH treatments covers the spectrum of disease, from WHO Functional Class (FC) II through to FC IV, with oral, inhaled and intravenous medications. As part of the Janssen Pharmaceutical Companies of Johnson & Johnson, we are working to create a world without disease. Transforming lives by finding new and better ways to prevent, intercept, treat and cure disease inspires us. We bring together the best minds and pursue the most promising science. We collaborate with the world for the health of everyone in it. Please beware of scam/fake recruitment offers that claim to be from Actelion. Such scams can be from various sources on the internet using either fake company websites, or sending unsolicited emails from fake Actelion recruiters. The intention is to obtain personal data or money from victims by offering jobs that do not exist. Actelion would never ask for payment to progress a job application. When in doubt please check if the position is posted on our corporate website https://www.actelion.com/careers before applying for such positions.

Website http://www.actelion.com
Ticker SIX:ATLN
Revenue $877 million
Employees 37 (37 on RocketReach)
Founded 1997
Phone +1 416-156-5656
Fax (650) 589-1501
Technologies
Industry Business Services, Research Services, Biopharma, Biotechnology, Drug Manufacturing & Research, Health Care, Pharmaceuticals, Science and Engineering, Healthcare, Medical
Web Rank 2 Million
Keywords Pharmaceutical, Drugs, Therapeutics, Biotech, Pharma, Healthcare, Health, Medicine, Treatment, Therapy, Clinical Trials, Drug Development, Research, Innovation, Pharmaceutical Research
Competitors Johnson & Johnson, Roche, Novartis, Pfizer, Sanofi, GSK, AstraZeneca, Bristol Myers Squibb, Boehringer Ingelheim, Takeda +45 more (view full list)
SIC SIC Code 873 Companies, SIC Code 87 Companies
NAICS NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 33 Companies, NAICS Code 3254 Companies

爱可泰隆医药技术(上海)有限公司 Questions

The 爱可泰隆医药技术(上海)有限公司 annual revenue was $877 million in 2026.

Catherine Lesage is the Senior Director, Clinical Science Pediatrics Program Head of 爱可泰隆医药技术(上海)有限公司.

37 people are employed at 爱可泰隆医药技术(上海)有限公司.

The NAICS codes for 爱可泰隆医药技术(上海)有限公司 are [325, 32, 33, 3254].

The SIC codes for 爱可泰隆医药技术(上海)有限公司 are [873, 87].

Top 爱可泰隆医药技术(上海)有限公司 Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users